MA
MAQAF.US Atlas Arteria Limited
- Market cap
- USD 3.87B
- P/E
- 53.2x
- P/B
- 1.08x
- ROE
- 8.9%
- Dividend yield
- 10.50%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is MAQAF.US undervalued?
Graham numberMAQAF.US trades 59.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Atlas Arteria Limited fundamental analysis
No fundamental analysis for Atlas Arteria Limited yet.
Atlas Arteria Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Atlas Arteria Limited
Atlas Arteria Limited owns, develops, and operates toll roads in France, Germany, Australia, Bermuda, and the United States. It holds 30.82% interest in the APRR motorway network, 30.85% interest in the ADELAC commuter road, and 30.79% interest in the A79 transversal link located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago, United States; and 100% interest in the Dulles Greenway located …
Full company profileAtlas Arteria Limited financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Atlas Arteria Limited annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.33M | 83.2M | 132M | 168M | 107M | 101M | 117M | 134M | 145M | 160M | 297M |
| Gross Profit | 1.33M | 68.0M | 100M | 39.1M | -13.5M | -9.05M | 116K | 16.4M | 139M | 13.5M | -31.2M |
| Operating Income | -166M | -21.1M | -86.5M | -2.60M | 48.5M | 47.8M | -24.9M | 87.6M | -8.10M | -7.50M | -72.3M |
| EBITDA | -166M | 593M | 218M | 164M | 38.8M | 36.7M | 401M | 426M | 444M | 64.4M | 58.7M |
| Net Income | 225M | 520M | 59.9M | -9.82M | -99.2M | 164M | 267M | 324M | 336M | 259M | 465M |
| EPS | 0.16 | 0.36 | 0.04 | -0.01 | -0.07 | 0.11 | 0.18 | 0.22 | 0.23 | 0.18 | 0.32 |
| Balance Sheet | |||||||||||
| Total Assets | 1.18B | 4.01B | 4.63B | 5.68B | 5.27B | 5.22B | 8.33B | 8.04B | 8.26B | 7.67B | 7.12B |
| Total Liabilities | 104M | 1.85B | 2.30B | 2.33B | 1.63B | 1.72B | 1.84B | 1.81B | 1.95B | 1.87B | 1.90B |
| Shareholders' Equity | 1.07B | 2.16B | 2.33B | 3.34B | 3.63B | 3.50B | 6.49B | 6.24B | 3.34B | 5.80B | 5.22B |
| Cash & Short-term Investments | 223M | 123M | 186M | 1.45B | 260M | 229M | 522M | 305M | 352M | 274M | 214M |
| Total Debt | 0.00 | 1.73B | 2.18B | 2.20B | 1.55B | 1.65B | 1.74B | 1.72B | 1.85B | 1.75B | 1.61B |
| Cash Flow | |||||||||||
| Operating Cash Flow | -15.6M | 18.1M | 23.1M | 315M | 25.4M | 40.0M | 73.8M | 84.7M | 93.2M | 614M | 1.29B |
| Capital Expenditure | 277K | 277K | 1.10M | 328K | 1.44M | 1.47M | 357K | 800K | 1.10M | 600K | 799K |
| Free Cash Flow | -15.6M | 17.8M | 22.0M | -328K | -1.44M | -1.47M | -357K | 713M | 92.1M | 613M | 1.29B |
| Ratios | |||||||||||
| ROE | 21.0% | 24.0% | 2.6% | -0.3% | -2.7% | 4.7% | 4.1% | 5.2% | 10.1% | 4.5% | 8.9% |
| ROA | 19.1% | 13.0% | 1.3% | -0.2% | -1.9% | 3.1% | 3.2% | 4.0% | 4.1% | 3.4% | 6.5% |
| Net Profit Margin | 16,887.4% | 624.3% | 45.2% | -5.9% | -93.0% | 162.9% | 228.7% | 241.4% | 231.7% | 162.2% | 156.7% |
| Debt to Equity | 0.00x | 0.80x | 0.94x | 0.66x | 0.43x | 0.47x | 0.27x | 0.28x | 0.55x | 0.30x | 0.31x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Atlas Arteria Limited dividends
- Dividend yield
- 10.50%
- Forward dividend
- 0.28 USD
- Payout ratio
- 223.7%
- Ex-dividend date
- Sep 23, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | AUD 580M | 0.40 | 223.7% |
| 2024 | AUD 580M | 0.40 | 172.8% |
| 2023 | AUD 580M | 0.40 | 179.4% |
| 2022 | AUD 388M | 0.27 | 145.5% |
| 2021 | AUD 273M | 0.19 | 167.0% |
| 2020 | AUD 105M | 0.07 | - |
| 2019 | AUD 152M | 0.10 | - |
| 2018 | AUD 85.2M | 0.06 | 142.3% |
| 2017 | USD 59.3M | 0.04 | 11.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1009:1000 on Sep 15, 2017.
Who owns Atlas Arteria Limited
- Insiders 68.09%
- Institutions 31.91%
- Public & others 0.00%
- Shares outstanding 1.45B
- Free float 447M
Atlas Arteria Limited company profile
- Company name
- Atlas Arteria Limited
- Ticker
- MAQAF.US
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Transportation Infrastructure
- Fiscal year end
- December
- Address
- 180 Flinders Street, Melbourne, VIC, Australia, 3000
- Phone
- 1800 267 108
- Website
- atlasarteria.com
About Atlas Arteria Limited
Atlas Arteria Limited owns, develops, and operates toll roads in France, Germany, Australia, Bermuda, and the United States. It holds 30.82% interest in the APRR motorway network, 30.85% interest in the ADELAC commuter road, and 30.79% interest in the A79 transversal link located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago, United States; and 100% interest in the Dulles Greenway located in Virginia, United States. Atlas Arteria Limited was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. The company was incorporated in 2009 and is based in Melbourne, Australia.
Atlas Arteria Limited management
10- Mr. Hugh Wehby BEc (Hons), DipInvRelCEO, MD & Director · born 1984
- Mr. Vincent Portal-BarraultChief Financial Officer
- Ms. Amanda BaxterChief Commercial Officer
- Tess PalmerGroup Director of Investor Relations & External Communications
- Navleen PrasadPublic Affairs Manager
- Ms. Geraldine LeslieGroup Executive of People, Culture & Sustainability
- Mr. Philip A. ShucetInterim CEO of Dulles Greenway
- Ms. Elisha Larkin B.Com.Joint Company Secretary
- Mr. Daniel Krutik B.Com., L.L.B.Joint Company Secretary
- Mr. Ryan Reynolds C.F.A.Specialist of Forecasting and Analysis